Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Hamdard Medicus. 2006; 49 (2): 34-45
Dans Anglais | IMEMR | ID: emr-164685

Résumé

The developments in therapeutics over the years have been punctuated by monumental innovation, which are though conceptually simple, have revolutionized the field due to their efficacy. The idea of introducing healthy nucleic acid into the nucleus for replacing the damaged one - Gene Therapy, may not have done that yet. However, the concept is so tempting that large amounts of research and resources have been committed to this area

2.
Hamdard Medicus. 2005; 48 (2): 86-95
Dans Anglais | IMEMR | ID: emr-172016

Résumé

Pharmacogenomics is the study of how an individual's genetic inheritance affects the body's response to drugs. Pharmacogenomic studies will produce benefits for both clinical research and standard practice. The larger potential advantages include the discovery of better drugs, elimination of poor candidate drugs early in the development process, and dramatic decreases in the size and expense of clinical trials. In pharmacogenomics instead of advising patients about potential side effects, pharmacists will determine what drugs are ideal for that patient, based on their genetic information. Pharmacist's historical role in drug advice and selection would make pharmacogenetic screening fit into the pharmacist's scope of practice

SÉLECTION CITATIONS
Détails de la recherche